Innovation & intellectual property · 22/10/20261 min read
Ping An Biomedical announces planned acquisition of three tumor cell-related medical technology patents to build a core oncology and biotech intellectual property portfolio
Summary
Ping An Biomedical (NASDAQ: PASW) signs LOI to acquire 3 tumor cell-related patents for $22.5M to build a core oncology and biotech IP portfolio.
Original source language: GlobeNewswire — Mergers and AcquisitionsOpen original release →